Max Healthcare to Buy 58.39% of Kalinga Hospital for ₹3 Billion
Key highlights
- Max Healthcare signed an agreement on April 8, 2026, to acquire 58.39% of Kalinga Hospital Ltd.
- The reported consideration for the Kalinga Hospital stake is ₹3.0 billion, or ₹300 crore.
- Max Healthcare's Q2 FY27 net profit was ₹4.1445 billion, down 15.6%, while revenue rose 16.8%.
- GIC's combined holding in Max Healthcare stood at 5.813% after selling 960,808 shares in September 2025.
powered by IRIS

Max Healthcare Institute Limited signed a share purchase agreement on April 8, 2026, to acquire a 58.39% stake in Kalinga Hospital Ltd. for ₹3.0 billion. The transaction gives Max Healthcare a majority interest in Kalinga Hospital and marks a further corporate acquisition by one of India’s largest healthcare organisations.
Know Max Healthcare Institute inside out
Results, valuation, peers and who's buying, in one view.
What has Max Healthcare agreed to acquire?
Max Healthcare Institute Limited has entered into a share purchase agreement to buy 58.39% of Kalinga Hospital Ltd. from Hospital Corporation of Orissa, Inc. for ₹3.0 billion. The agreement was entered into on April 8, 2026.
A 58.39% holding represents a majority stake in Kalinga Hospital. The disclosed transaction is structured as a purchase of shares from the existing shareholder, Hospital Corporation of Orissa, Inc., rather than a statement of a fresh equity issue by Kalinga Hospital.
The available information identifies the buyer, seller, stake size, transaction value and agreement date. It does not specify the number of shares involved, the per-share acquisition price, the funding source, completion date, or other transaction conditions. Those details should not be assumed from the share purchase agreement announcement alone.
How did the Kalinga Hospital transaction unfold?
The transaction was formalised through a share purchase agreement on April 8, 2026. Under that agreement, Max Healthcare will acquire the 58.39% interest held by Hospital Corporation of Orissa, Inc. in Kalinga Hospital.
The ₹3.0 billion consideration is the reported value for the majority stake. In crore terms, ₹3.0 billion equals ₹300 crore, using a common unit conversion of ₹1 billion to ₹100 crore. Normalising the amount to billions makes it easier to compare with other corporate transactions.
No direct statement from Max Healthcare, Hospital Corporation of Orissa, Inc., or Kalinga Hospital has been provided in the source material beyond the reported agreement terms. There is also no disclosed statement on management arrangements, operational integration, hospital capacity, or the post-transaction ownership of minority shareholders.
Why does a 58.39% stake matter for Max Healthcare?
A 58.39% stake gives Max Healthcare a majority position in Kalinga Hospital. Majority ownership is significant because it establishes Max Healthcare as the controlling shareholder, subject to the terms of the agreement and applicable requirements that are not detailed in the provided information.
For Max Healthcare, the acquisition adds a new corporate asset to a healthcare platform that describes itself as one of India’s largest healthcare organisations. The company’s present form followed Radiant Life Care Pvt. Ltd.’s acquisition of a 49.7% stake in the erstwhile Max Healthcare Institute Limited and the subsequent amalgamation of Max Healthcare with Radiant.
That earlier corporate history shows that ownership changes and consolidation have been an important part of Max Healthcare’s development. In 2018, KKR and Radiant bought a 49.7% stake in Max Healthcare for ₹2,120 crore. Later, in August 2022, Kayak Investments Holding Pte. Ltd. sold 260,196,762 shares, representing about 26.835% of the company, through a block trade.
Got a follow-up? Ask IRIS
What do the reported financial and ownership data show?
The supplied information says Max Healthcare’s Q2 FY27 net profit declined 15.6% to ₹4.1445 billion, while revenue increased 16.8% on higher patient demand. The reported fall in profit was attributed to higher operating and tax expenses.
These financial data provide context for the acquisition because they show revenue growth alongside pressure on profitability during the reported quarter. However, the provided material does not link the Kalinga Hospital agreement to Max Healthcare’s Q2 FY27 results, and it does not quantify any expected financial contribution from Kalinga Hospital.
The company has also seen changes in institutional holdings. GIC Private Limited, acting for the Government of Singapore and the Monetary Authority of Singapore, sold 960,808 Max Healthcare shares in September 2025. Its combined holding fell from 5.912% to 5.813%, or 56,515,686 equity shares.
How could the agreement affect investors and hospital operations?
For investors, the announced consideration of ₹3.0 billion is the clearest disclosed financial measure of the transaction. It represents the cost agreed for the 58.39% stake, but the source does not provide information on how Max Healthcare intends to finance the purchase or the timing of any cash outflow.
The company’s reported Q2 FY27 revenue growth of 16.8% indicates higher patient demand during that period, while the 15.6% decline in net profit highlights the effect of operating and tax expenses. These figures are relevant context, but no conclusion can be drawn from the provided data about whether the Kalinga Hospital acquisition will change future revenue, margins, earnings or valuation.
For Kalinga Hospital, the disclosed impact is a change in majority share ownership. The source does not state whether there will be changes in clinical services, staffing, pricing, facilities, suppliers, management, or patient operations. It also does not state whether any local community or employee consultation has occurred.
Conclusion
Max Healthcare has agreed to acquire a 58.39% majority stake in Kalinga Hospital for ₹3.0 billion from Hospital Corporation of Orissa, Inc. The agreement is notable because it transfers majority ownership of Kalinga Hospital to a large listed healthcare organisation, while the available disclosure limits confirmed facts to the stake, consideration, parties and April 8, 2026 agreement date.
Investors should watch for any subsequent company disclosures on completion, financing, regulatory steps, Kalinga Hospital’s operational profile and the transaction’s financial treatment. The source does not disclose a completion target, expected earnings contribution, or integration plan, leaving these matters unresolved.


